Belvedere Trading Portfolio holdings
AUM
$1.27B
1-Year Return
0.64%
This Quarter Return
+0.14%
1 Year Return
+0.64%
3 Year Return
+2.43%
5 Year Return
+18%
10 Year Return
–
AUM
$227M
AUM Growth
+$51.9M
(+30%)
Cap. Flow
-$2.92M
Cap. Flow
% of AUM
-1.29%
Top 10 Holdings %
Top 10 Hldgs %
80.26%
Holding
769
New
156
Increased
37
Reduced
43
Closed
275
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$114M |
| 2 |
Meta Platforms (Facebook)
META
|
$18.1M |
| 3 |
Avantis US Small Cap Value ETF
AVUV
|
$4.28M |
| 4 |
Direxion Daily Semiconductor Bear 3X Shares
SOXS
|
$2.81M |
| 5 |
iShares Select Dividend ETF
DVY
|
$1.67M |
Top Sells
| 1 |
Tesla
TSLA
|
$95.2M |
| 2 |
Amazon
AMZN
|
$26.4M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
$5.27M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
$2.9M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
$2.1M |
Sector Composition
| 1 | Communication Services | 12.72% |
| 2 | Consumer Discretionary | 11.48% |
| 3 | Technology | 3.29% |
| 4 | Healthcare | 3% |
| 5 | Industrials | 2.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HMPT
201
DELISTED
Home Point Capital, Inc Common Stock
HMPT
| $22.8K | ﹤0.01% |
+11,805
| New | +$22.8K |
|
202
BioVie
BIVI
$12M
| $22.7K | ﹤0.01% |
+28
| New | +$22.7K |
|
203
Acadia Pharmaceuticals
ACAD
$4.3B
| $21.9K | ﹤0.01% |
+1,166
| New | +$21.9K |
|
204
Altice USA
ATUS
$1.09B
| $21.6K | ﹤0.01% |
6,309
-5,604
| -47% | -$19.2K |
|
205
ImmunityBio
IBRX
$2.26B
| $21.6K | ﹤0.01% |
11,846
-8,064
| -41% | -$14.7K |
|
206
PharmaCyte Biotech
PMCB
$6.41M
| $20.8K | ﹤0.01% |
+7,135
| New | +$20.8K |
|
207
Vanguard Tax-Exempt Bond Index Fund
VTEB
$38.1B
| $20.3K | ﹤0.01% |
+400
| New | +$20.3K |
|
208
Noodles & Co
NDLS
$32M
| $17.2K | ﹤0.01% |
+3,555
| New | +$17.2K |
|
209
Hecla Mining
HL
$5.93B
| $17.2K | ﹤0.01% |
+2,721
| New | +$17.2K |
|
|
CANO
210
DELISTED
Cano Health, Inc.
CANO
| $17.1K | ﹤0.01% |
188
-68
| -27% | -$6.19K |
|
|
LLAP
211
DELISTED
Terran Orbital Corporation
LLAP
| $16.5K | ﹤0.01% |
+8,965
| New | +$16.5K |
|
212
Amplify Energy
AMPY
$161M
| $15.4K | ﹤0.01% |
2,239
-14,343
| -86% | -$98.5K |
|
213
Uranium Energy
UEC
$5.01B
| $13.3K | ﹤0.01% |
4,605
-4,567
| -50% | -$13.2K |
|
|
DMTK
214
DELISTED
DermTech, Inc. Common Stock
DMTK
| $12.5K | ﹤0.01% |
+3,408
| New | +$12.5K |
|
|
MESO
215
Mesoblast
MESO
$1.73B
| $12.5K | ﹤0.01% |
1,902
+1,011
| +113% | +$6.65K |
|
216
Summit Therapeutics
SMMT
$17.7B
| $12.3K | ﹤0.01% |
+7,049
| New | +$12.3K |
|
217
Vertical Aerospace
EVTL
$444M
| $12.3K | ﹤0.01% |
580
+463
| +396% | +$9.81K |
|
|
VRAY
218
DELISTED
ViewRay, Inc.
VRAY
| $12K | ﹤0.01% |
3,460
-4,164
| -55% | -$14.4K |
|
219
SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
$3.84B
| $11.6K | ﹤0.01% |
+116
| New | +$11.6K |
|
220
Esperion Therapeutics
ESPR
$510M
| $11.5K | ﹤0.01% |
+7,256
| New | +$11.5K |
|
221
Vanguard Small-Cap Growth ETF
VBK
$20.2B
| $10.6K | ﹤0.01% |
+49
| New | +$10.6K |
|
|
EMBK
222
DELISTED
Embark Technology, Inc. Common Stock
EMBK
| $10.6K | ﹤0.01% |
+3,770
| New | +$10.6K |
|
223
Alaunos Therapeutics
TCRT
$4.27M
| $9.32K | ﹤0.01% |
99
-523
| -84% | -$49.2K |
|
224
Relay Therapeutics
RLAY
$690M
| $7.54K | ﹤0.01% |
+458
| New | +$7.54K |
|
|
ENFY
225
Enlightify Inc.
ENFY
$16.9M
| $7.02K | ﹤0.01% |
1,716
-6,000
| -78% | -$24.5K |
|